Dr. Dale Schenk, PhD. developer of the Alzheimer's Vaccine. Comments on events leading to the development of the Alzheimer's Vaccine and the overview of continuing clinical trial research - forms Dr. Schenk's opinions regarding Alzheimer's Treatment. Dr. Schenk, speculated that a conditioned amount of a beta amyloid injected into the body - would call up an anti-body response - stimulating the body's immune system to remove excess a beta amyloid plaque from the body. In clinical trials, the compound has proven to be the first treatment that modifies the disease process and produces an effective clearing of the a beta plaque compound - research continues to see how this process effects the quality of life for the patients.
Powered by, Enterprise
Enterprise